When US President Donald Trump announced a 100% tariff on imported branded pharmaceuticals from October 1, 2025, markets across Asia trembled. Shares of leading drugmakers in India, Japan, and Australia shed billions in value within hours. But while investors felt the sting first, the true cost of Trump’s tariff tantrum will be borne by patients […]The post Trump’s pharma tariffs will make the world a sicker place appeared first on Asia Times.